What is CERO stock price today?

CERO (Cero Therapeutics Holdings Inc) stock is trading at $0.04 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CERO stock going up or down today?

CERO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CERO stock now?

The decision to buy CERO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CERO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CERO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CERO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CERO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CERO's P/E ratio?

P/E ratio data for CERO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CERO's market cap?

CERO (Cero Therapeutics Holdings Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CERO's price to book ratio?

Price-to-book ratio for CERO is available on our dashboard along with other valuation metrics.

Does CERO pay dividends?

CERO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CERO's dividend yield?

CERO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CERO stock a good long-term investment?

CERO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CERO's revenue growth rate?

Revenue growth data for CERO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CERO are available on our dashboard with complete income statement analysis.

What are the risks of investing in CERO?

Key risks for CERO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CERO compare to its competitors?

Compare CERO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CERO's performance and positioning.

What is CERO's stock price target for 2026?

Our AI model provides price targets for CERO based on fundamental analysis: Bull case $0.05 (+30%), Base case $0.05 (+15%), Bear case $0.04 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CERO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CERO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CERO's next earnings report?

CERO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CERO - Cero Therapeutics Holdings Inc

NYSE * Health Care * Biotechnology

$0.04

+$0.00 (+0.00%)

About Cero Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

CERO Key Statistics

Market Cap

$0.84M

EPS

$-2.67

Employees

How CERO Compares to Peers

CERO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CERO(This stock)	$844.11K	N/A	0%	0.0%	-
AMGNAmgen Inc	$191.53B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

Cero Therapeutics Holdings Inc Company Information

Headquarters: California; U.S.A
Website: www.cero.bio
Sector: Health Care
Industry: Biotechnology

Data Updated: April 19, 2026 at 4:37 AM EDT

Ready to invest in CERO?

Commission-free trading available. Affiliate links.

Upcoming Events for CERO

Dashboard

Enter a ticker to analyze